Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular genetic tests for FLT3, NPM1, and CEBPA in acute myeloid leukemia.

Methods in molecular biology (Clifton, N.J.) - 1 Jan 2013

Zhang Qing, Bai Shaochun, Vance Gail H

Abstract excerpt

Patients with acute myeloid leukemia (AML) and a normal karyotype constitute the single largest cytogenetic group of AML. It is important to identify prognostic markers that predict patients' outcome more precisely. The presence of mutations in FLT3 (FMS-like tyrosine kinase 3), NPM1 (Nucleophosmin), and CEBPA (CCAAT/enhancer-binding protein alpha) genes hold prognostic significance in patients with AML and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CCAAT-Enhancer-Binding Proteins
Share to fms-Like Tyrosine Kinase 3

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression Regulation, Leukemic

Share to Genetic Testing

Share to Karyotype

Share to Leukemia, Myeloid, Acute

Share to Nuclear Proteins

Share to Nucleophosmin

Source

Identifiers

PMID: 23666693
DOI: 10.1007/978-1-62703-357-2_7

Genes

FLT3
NPM1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular genetic tests for FLT3, NPM1, and CEBPA in acute myeloid leukemia.PMID 23666693Read ↗

Rapid and sensitive screening for CEBPA mutations in acute myeloid leukaemia.Semantic proximity Read ↗

Establishment of a Multiplex PCR-Based Procedure for Detection of Most Common Mutations in NPM1, FLT3 in Acute Myeloid Leukemia Patients.Semantic proximity Read ↗

Simultaneous detection of NPM1 and FLT3-ITD mutations by capillary electrophoresis in acute myeloid leukemia.Semantic proximity Read ↗

Prevalence, clinical profile, and prognosis of NPM mutations in AML with normal karyotypeSemantic proximity Read ↗

Fragment length analysis screening for detection of CEBPA mutations in intermediate-risk karyotype acute myeloid leukemia.Semantic proximity Read ↗

Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance.Semantic proximity Read ↗

A clinical grade sequencing-based assay for CEBPA mutation testing: report of a large series of myeloid neoplasms.Semantic proximity Read ↗

FMS-Like Tyrosine Kinase 3 (FLT3) and Nucleophosmin 1 (NPM1) in Iranian Adult Acute Myeloid Leukemia Patients with Normal Karyotypes: Mutation Status and Clinical and Laboratory Characteristics.Semantic proximity Read ↗

Prognostic significance of FLT3 internal tandem duplication, nucleophosmin 1, and CEBPA gene mutations for acute myeloid leukemia patients with normal karyotype and younger than 60 years: a systematic review and meta-analysis.Semantic proximity Read ↗

Fms like tyrosine kinase (FLT3) and nucleophosmin 1 (NPM1) mutations in de novo normal karyotype acute myeloid leukemia (AML).Semantic proximity Read ↗

Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype.Semantic proximity Read ↗

The Clinical Utility of FLT3 Mutation Testing in Acute Leukemia: A Canadian Consensus.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.